Home Other Building Blocks Sulfamide

Sulfamide

CAS No.:
7803-58-9
Catalog Number:
AG003UGP
Molecular Formula:
H4N2O2S
Molecular Weight:
96.1090
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$13
- +
25g
98%
In Stock USA
United States
$19
- +
100g
98%
In Stock USA
United States
$63
- +
500g
98%(HPLC)
In Stock USA
United States
$298
- +
Product Description
Catalog Number:
AG003UGP
Chemical Name:
Sulfamide
CAS Number:
7803-58-9
Molecular Formula:
H4N2O2S
Molecular Weight:
96.1090
MDL Number:
MFCD00011606
IUPAC Name:
sulfamide
InChI:
InChI=1S/H4N2O2S/c1-5(2,3)4/h(H4,1,2,3,4)
InChI Key:
NVBFHJWHLNUMCV-UHFFFAOYSA-N
SMILES:
NS(=O)(=O)N
EC Number:
232-262-9
UNII:
VS7TZW634V
NSC Number:
252
Properties
Complexity:
85.3  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
95.999g/mol
Formal Charge:
0
Heavy Atom Count:
5  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
96.104g/mol
Monoisotopic Mass:
95.999g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
94.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.7  
Literature
Title Journal
Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine. Bioorganic & medicinal chemistry 20130601
Anion inhibition studies of an α-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Bioorganic & medicinal chemistry letters 20120901
Anion inhibition studies of an α-carbonic anhydrase from the living fossil Astrosclera willeyana. Bioorganic & medicinal chemistry letters 20120201
Inhibition studies with anions and small molecules of two novel β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium. Bioorganic & medicinal chemistry letters 20110615
Purification and inhibition studies with anions and sulfonamides of an α-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii. Bioorganic & medicinal chemistry 20110315
Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. Bioorganic & medicinal chemistry letters 20110115
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? Bioorganic & medicinal chemistry 20110101
Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV. Bioorganic & medicinal chemistry letters 20100615
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with anions. Bioorganic & medicinal chemistry letters 20090815
Carbonic anhydrase inhibitors: the membrane-associated isoform XV is highly inhibited by inorganic anions. Bioorganic & medicinal chemistry letters 20090215
Carbonic anhydrase inhibitors: inhibition studies of a coral secretory isoform with inorganic anions. Bioorganic & medicinal chemistry letters 20090201
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with anions. Bioorganic & medicinal chemistry letters 20081215
Carbonic anhydrase inhibitors: inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with simple anions. Bioorganic & medicinal chemistry letters 20080915
Carbonic anhydrase inhibitors: the inhibition profiles of the human mitochondrial isoforms VA and VB with anions are very different. Bioorganic & medicinal chemistry 20071101
Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions. Bioorganic & medicinal chemistry letters 20070315
Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions. Bioorganic & medicinal chemistry letters 20070215
Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions. Bioorganic & medicinal chemistry letters 20060615
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors. Bioorganic & medicinal chemistry letters 20050502
Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate. Bioorganic & medicinal chemistry letters 20050201
Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides. Bioorganic & medicinal chemistry letters 20041220
Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions. Bioorganic & medicinal chemistry letters 20041206
Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions. Bioorganic & medicinal chemistry letters 20041101
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the methanoarchaeon Methanobacterium thermoautotrophicum (Cab) with anions. Bioorganic & medicinal chemistry letters 20040906
Carbonic anhydrase inhibitors: inhibition of cytosolic isozymes I and II with sulfamide derivatives. Bioorganic & medicinal chemistry letters 20030310
Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorganic & medicinal chemistry letters 20030310
Properties